High-cost drug claims lead to 20-times greater cost per claim for small plan sponsors
A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director…
- By: Suzanne Lepage
- January 22, 2024 January 18, 2024
- 08:00